The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Altech Batteries (ASX:ATC) announced on Tuesday its successful share purchase plan, raising $3.7M to progress its European lithium plans.

The company received applications for some 57.24M shares at 6.5cps and 28.6M free-attaching options exercisable at 8cps on 30 April 2026.

“On behalf of the Board of Directors, I wish to thank all eligible shareholders that participated in the SPP and for the support extended to Altech as it moves forward with both its CERENERGY battery project as well as Silumina Anodes battery materials project,” Altech chief Iggy Tan said.

CERENERGY refers to Altech’s development of modular energy storage batteries using a superior tech compared to lithium-ion, whereas Silumina Anodes relates to Altech’s development of silicon-based anode material for batteries.

“I am also cognisant of the market’s expectation in relation to the fabrication of the two 60KWh CERENERGY battery prototypes as well as the commissioning of the Silumina Anodes pilot plant, and funds received from the SPP will be applied towards this,” Tan added.

“With the positive Definitive Feasibility Study and excellent economics for the 120MWh CERENERGY battery project having been recently released in March 2024, Altech is also focused on securing offtake as well as finance to commence plant construction.”

ATC last traded at 6.2cps.

atc by the numbers
More From The Market Online

Listen: HotCopper Wire Podcast #047 – Maybe just send an email next time, Albo

In this week’s HotCopper Wire episode, Isaac McIntyre and Jonathon Davidson break down (poke holes in) Albo’s national address from 7PM Wednesday, talk
The Market Online Video

Introducing Prairie Lithium: Saskatchewan’s permitted lithium project ready to scale

We've spoken to Prairie Lithium founder Zach Maurer about the explorer's overall mission, right after Macquarie's…
The Market Online Video

US growth, injectable iron pipeline: How AFT Pharma is driving toward $300 million by FY27

AFT Pharmaceuticals (ASX:AFP) is in a red-hot position as we head straight into FY26’s fourth quarter in Australia, and
The Market Online graphic with ASX-branded charts and the text "HotCopper Highlights" centred in white.

HotCopper Highlights, Week 15: Santos, Karoon, Viva all riding the Iran-fuelled Energy rollercoaster

Hello, hello, and welcome to HotCopper Highlights for Week 15, CY26, I’m Isaac McIntyre.